CLDX vs. TSLA
CLDX (Celldex Therapeutics, Inc.) and TSLA (Tesla, Inc.) are both stocks. CLDX operates in Biotechnology (Healthcare), while TSLA operates in Auto Manufacturers (Consumer Cyclical). Over the past 10 years, CLDX returned -5.67%/yr vs 35.29%/yr for TSLA. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
CLDX vs. TSLA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CLDX achieves a 40.13% return, which is significantly higher than TSLA's -30.80% return. Over the past 10 years, CLDX has underperformed TSLA with an annualized return of -5.67%, while TSLA has yielded a comparatively higher 35.29% annualized return.
CLDX
- 1D
- -1.10%
- 1M
- -0.81%
- 6M
- 54.72%
- YTD
- 40.13%
- 1Y
- 71.52%
- 3Y*
- 3.07%
- 5Y*
- -2.75%
- 10Y*
- -5.67%
- ALL TIME*
- -5.66%
TSLA
- 1D
- 0.76%
- 1M
- -20.90%
- 6M
- -27.69%
- YTD
- -30.80%
- 1Y
- 2.84%
- 3Y*
- 6.03%
- 5Y*
- 6.32%
- 10Y*
- 35.29%
- ALL TIME*
- 40.79%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $36.64M | $35.57M | $33.98M | |
TSLA Tesla, Inc. | $15.40B | $15.32B | $18.68B |
CLDX vs. TSLA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CLDX Celldex Therapeutics, Inc. | 40.13% | 7.48% | -36.28% | -11.02% | 15.35% | 120.55% | 685.65% | -24.88% | -93.03% | -19.77% |
TSLA Tesla, Inc. | -30.80% | 11.36% | 62.52% | 101.72% | -65.03% | 49.76% | 743.44% | 25.70% | 6.89% | 45.70% |
Correlation
The correlation between CLDX and TSLA is 0.17, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.17 |
Correlation (3Y) Balances recent behavior with more history. | 0.19 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.27 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.23 |
Correlation (All Time) Calculated using the full available price history since Jun 29, 2010 | 0.23 |
Fundamentals
CLDX:
$2.53B
TSLA:
$1.23T
CLDX:
-$4.27
TSLA:
$1.08
CLDX:
3.09K
TSLA:
10.62
CLDX:
5.55
TSLA:
12.68
CLDX:
$820.00K
TSLA:
$103.62B
CLDX:
$805.00K
TSLA:
$19.53B
CLDX:
-$216.32M
TSLA:
$10.41B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLDX vs. TSLA — Risk / Return Rank
CLDX
TSLA
CLDX vs. TSLA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Celldex Therapeutics, Inc. (CLDX) and Tesla, Inc. (TSLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLDX | TSLA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.29 | ||
| Sortino ratioReturn per unit of downside risk | +1.80 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.04 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 3.04 | 0.02 | +3.01 |
| Martin ratioReturn relative to average drawdown | 7.81 | 0.06 | +7.74 |
Loading charts...
Drawdowns
CLDX vs. TSLA - Drawdown Comparison
The maximum CLDX drawdown since its inception was -99.73%, which is greater than TSLA's maximum drawdown of -73.63%. Use the drawdown chart below to compare losses from any high point for CLDX and TSLA.
Loading charts...
Drawdown Indicators
| CLDX | TSLA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.73% | -73.63% | -26.10% |
Max Drawdown (1Y)Largest decline over 1 year | -24.23% | -39.10% | +14.87% |
Max Drawdown (3Y)Largest decline over 3 years | -70.84% | -53.77% | -17.07% |
Max Drawdown (5Y)Largest decline over 5 years | -73.11% | -73.63% | +0.52% |
Max Drawdown (10Y)Largest decline over 10 years | -97.90% | -73.63% | -24.27% |
Current DrawdownCurrent decline from peak | -93.29% | -36.47% | -56.82% |
Average DrawdownAverage peak-to-trough decline | -78.14% | -22.72% | -55.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.40% | 15.31% | -5.91% |
Volatility
CLDX vs. TSLA - Volatility Comparison
The current volatility for Celldex Therapeutics, Inc. (CLDX) is 13.11%, while Tesla, Inc. (TSLA) has a volatility of 20.43%. This indicates that CLDX experiences smaller price fluctuations and is considered to be less risky than TSLA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLDX | TSLA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.11% | 20.43% | -7.32% |
Volatility (6M)Calculated over the trailing 6-month period | 37.30% | 34.55% | +2.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.28% | 46.36% | +9.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 57.29% | 59.65% | -2.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.91% | 59.43% | +18.48% |
Dividends
CLDX vs. TSLA - Dividend Comparison
Neither CLDX nor TSLA has paid dividends to shareholders.
Financials
CLDX vs. TSLA - Financials Comparison
This section allows you to compare key financial metrics between Celldex Therapeutics, Inc. and Tesla, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CLDX and TSLA have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TSLA has higher volatility (20.43%) compared to CLDX (13.11%). In terms of maximum drawdown, CLDX dropped -99.73% vs TSLA's -73.63%.
CLDX currently has the higher Sharpe Ratio (1.31 vs 0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CLDX and TSLA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer